Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Tech Monitor.
Press releases published on May 2, 2025
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
GlobeNewswire
·
May 2, 2025
Court will not hear cross-claim that challenges the PH-ILD indication in the tentatively approved NDA for YUTREPIA FDA can grant final approval of YUTREPIA after blocking regulatory exclusivity expires on May 23, 2025 MORRISVILLE, N.C., May 02, 2025 (GLOBE …
Result of General Meeting
GlobeNewswire
·
May 2, 2025
May 2, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …
Microchip Technology Appoints Long-Time TSMC Executive Rick Cassidy to Its Board of Directors
GlobeNewswire
·
May 2, 2025
CHANDLER, Ariz., May 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, today announced that Rick Cassidy, Senior Vice President of Corporate …
Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
GlobeNewswire
·
May 2, 2025
XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company granted inducement awards to purchase up …
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
May 2, 2025
FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …
NurExone Expands European Engagement with Investor Events in Germany and Switzerland
GlobeNewswire
·
May 2, 2025
TORONTO and HAIFA, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system …
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
NAARDEN, the Netherlands and MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
WESTLAKE VILLAGE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …
One-on-One Mentorship Model Sets TradingSTO Apart in the Australian Crypto Space
GlobeNewswire
·
May 2, 2025
London, UK, May 02, 2025 (GLOBE NEWSWIRE) -- As algorithmic trading tools and generic crypto bots flood the market, a different kind of platform is quietly dominating the conversation among serious Australian investors. TradingSTO, an emerging leader in …
AWS Supports BLOX Markets with Scalable Cloud Infrastructure for Openpool Trading Venue’s Development and Testing Environments
GlobeNewswire
·
May 2, 2025
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- BLOX Markets has selected Amazon Web Services (AWS) to serve as the technology infrastructure supporting the development and testing environments of Openpool, a new retail-focused U.S. equities trading venue. …
Sutter Health Study Highlights the Power and Potential of Ambient AI to Improve Clinician Well-Being
GlobeNewswire
·
May 2, 2025
Sacramento, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Researchers at Sutter Health, led by Cheryl Stults, Ph.D., found that an innovative ambient artificial intelligence platform showed promising results in easing the burden of clinical documentation for …
NETSOL Technologies Sets Fiscal Third Quarter 2025 Conference Call for Wednesday, May 14, 2025, at 9:00 AM ET
GlobeNewswire
·
May 2, 2025
ENCINO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, will hold a conference call on Wednesday, May 14, 2025, at 9:00 AM ET to discuss its …
SIMPPLE Ltd. Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
GlobeNewswire
·
May 2, 2025
Singapore, May 02, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management (FM) sector, today announced that on April 28, 2025, the Company received formal …
ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
GlobeNewswire
·
May 2, 2025
Vagal Neuromodulation Offers a Novel Approach to Treating Diabetes and Hypoglycemia Device Demonstrates the Ability to Modulate Glucose Levels Without Cardiac Side Effects, Overcoming a Key Limitation Of Conventional Vagal Stimulation Techniques IRVINE, …
Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT
GlobeNewswire
·
May 2, 2025
REYKJAVIK, Iceland, May 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for …
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire
·
May 2, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 2 May 2025 at 15.15 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has …
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
GlobeNewswire
·
May 2, 2025
LEIDEN, Netherlands …
Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis
GlobeNewswire
·
May 2, 2025
BRISBANE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced an upcoming podium …
Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
GlobeNewswire
·
May 2, 2025
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the first quarter ended March 31, 2025, …